The Study
Aspartame Promotes Ovarian Cancer Progression: A Multi-omics Study Integrating Mendelian Randomization, Network Toxicology, and In Vitro Validation.
This study didn't watch people eat aspartame and see if they got cancer. Instead, it used computer tricks and test-tube cells to guess if aspartame might be linked to cancer. So it's like a really smart guess—not proof.
Analysis score
Maximum 0 for a computational/algorithm study.
Where the score came from
Scientists studied if a sugar-free sweetener called aspartame might make ovarian cancer worse by looking at genes, computer models, and lab cells.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1A 2.1x higher risk sounds scary, but ovarian cancer is rare — so even if this link is real, most people who drink diet soda won’t get it.
- 2Still, it’s a warning sign worth investigating further.
- 3People with genes linked to drinking more aspartame had more than double the risk of ovarian cancer (2.1x higher).
- 4Aspartame also stuck to 3 key proteins (AURKA, CCND1, RAD51) and made cancer cells grow faster in the lab.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Year
2025
Authors
Qingquan Gong, Dingyu Liang, Yongjin Luo, Chao Yang, Yihua Yang, Shujie Zhang
Related Content
Claims (6)
The International Agency for Research on Cancer has categorized aspartame as a substance that may cause cancer in humans, based on limited scientific evidence.
People with genetic markers suggesting higher aspartame consumption have a higher rate of ovarian cancer compared to those without those markers.
AURKA, CCND1, and RAD51 genes show increased activity in ovarian cancer tissues, and computational analysis suggests aspartame may interact with these genes.
People with higher levels of the CCND1 gene have a higher risk of developing ovarian cancer, based on genetic data from two large population studies.
Aspartame forms stable physical interactions with AURKA, CCND1, and RAD51 proteins in computer simulations, which may interfere with cell cycle control and DNA repair processes in ovarian cells.
Exposing ovarian cancer cells to aspartame in a laboratory setting increases their cancerous behaviors and raises the activity levels of three specific genes linked to tumor growth.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.